Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityNo recent work listed

Lixin Jiang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0853-9329; OpenAlex author ID A5028707595. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
9
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: 2 papers · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 5

  1. CD133-Targeted Hybrid Nanovesicles for Fluorescent/Ultrasonic Imaging-Guided HIFU Pancreatic Cancer Therapy. Last author DOI 10.2147/ijn.s391382↗
  2. USP5 promotes tumorigenesis and progression of pancreatic cancer by stabilizing FoxM1 protein. Co-author DOI 10.1016/j.bbrc.2017.08.040↗
  3. Efficacy of sub-threshold focused ultrasound irradiation against pancreatic cancer xenografts evaluated using magnetic resonance imaging. Last author DOI 10.18632/oncotarget.19241↗
  4. Treatment of pancreatic cancer in a nude mouse model using high-intensity focused ultrasound. Co-author DOI 10.3892/etm.2012.744↗
  5. Cell apoptosis and proliferation inhibition of pancreatic cancer induced by sub-threshold focused ultrasound (FUS). First author DOI 10.1016/j.ejrad.2011.03.023↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rui Wang · 2 shared papers, 2017–2023 · strength 0.26
  2. Qian Yu · 1 shared paper, 2023 · strength 0.18
  3. Yijing Yao · 1 shared paper, 2023 · strength 0.18
  4. Qian Guo · 3 shared papers, 2012–2017 · strength 0.18
  5. Bing Hu · 2 shared papers, 2013–2017 · strength 0.13
  6. Yong‐Xiang Wang · 1 shared paper, 2017 · strength 0.09
  7. Xinyan Li · 1 shared paper, 2017 · strength 0.09
  8. Li Chen · 1 shared paper, 2013 · strength 0.05
  9. Bing Quan Hu · 1 shared paper, 2012 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.